(NASDAQ: IKNA) Ikena Oncology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.68%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.82%.
Ikena Oncology's earnings in 2025 is -$41,707,000.On average, 2 Wall Street analysts forecast IKNA's earnings for 2025 to be -$27,989,704, with the lowest IKNA earnings forecast at -$28,472,285, and the highest IKNA earnings forecast at -$27,507,123. On average, 1 Wall Street analyst forecast IKNA's earnings for 2026 to be -$36,193,583, with the lowest IKNA earnings forecast at -$36,193,583, and the highest IKNA earnings forecast at -$36,193,583.
In 2027, IKNA is forecast to generate -$46,569,077 in earnings, with the lowest earnings forecast at -$70,456,842 and the highest earnings forecast at -$22,681,312.